期刊
CHEMICAL SOCIETY REVIEWS
卷 48, 期 3, 页码 771-813出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8cs00304a
关键词
-
资金
- CRI project from the National Research Foundation (NRF) of Korea [2018R1A3B1052702]
- Shangha University
- U.S. National Institutes of Health [CA68682, CA232765]
- Robert A. Welch Foundation [F-0018]
- Shanghai University
Hypoxia is a state of low oxygen tension found in numerous solid tumours. It is typically associated with abnormal vasculature, which results in a reduced supply of oxygen and nutrients, as well as impaired delivery of drugs. The hypoxic nature of tumours often leads to the development of localized heterogeneous environments characterized by variable oxygen concentrations, relatively low pH, and increased levels of reactive oxygen species (ROS). The hypoxic heterogeneity promotes tumour invasiveness, metastasis, angiogenesis, and an increase in multidrug-resistant proteins. These factors decrease the therapeutic efficacy of anticancer drugs and can provide a barrier to advancing drug leads beyond the early stages of preclinical development. This review highlights various hypoxia-targeted and activated design strategies for the formulation of drugs or prodrugs and their mechanism of action for tumour diagnosis and treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据